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Triclocarban (TCC) is an antimicrobial agent that is used in detergents, soaps and other personal hygiene
products. Similarly to triclosan the widespread use of TCC has raised concerns about its endocrine poten-
tial. In luciferase-based reporter assays TCC has been shown to enhance estrogenic and androgenic activ-
ities following cellular coexposure with estrogen or dihydrotestosterone, respectively. The present study
demonstrates that although coexposure with TCC enhances the estrogenic and androgenic readout of
luciferase-based reporter cell lines such as HeLa9908 and MDA-kb2, it fails to act as a xenoandrogen
on transcriptional level, nor does it induce cell proliferation in the estrogen sensitive E-screen. In addition
TCC did not alter the expression of estrogen responsive genes in human mammary carcinoma MCF-7 cells
exposed to 17b-estradiol, bisphenol A, butylparaben or genistein.
However, TCC was shown to interfere with the regulon of the aryl hydrocarbon receptor (AhR) as TCC
showed a costimulatory effect on transcription of CYP1A1 and CYP1B1, effectively lowering the transcrip-
tional threshold for both genes in the presence of estrogens. It thus seems, that while the induction of the
respective luciferase reporter assays by TCC is an unspeciﬁc false positive signal caused by luciferase sta-
bilisation, TCC has the potential to interfere with the regulatory crosstalk of the estrogen receptor (ER)
and the AhR regulon.
 2013 Elsevier Ltd. Open access under CC BY-NC-ND license. 1. Introduction
Triclocarban (3,4,40-trichlorocarbanilide, TCC) is an antimicro-
bial agent commonly added to detergents and personal hygiene
products including liquid soaps or soap bars. Apart from its diphen-
ylurea moiety TCC is structurally similar to other widely used anti-
microbials such as triclosan (TCS) and hexachlorophene (HCP)
(Fig. 1). The use in soaps results in direct human exposure. Liquid
soaps contain up to 1.5% of TCC (SCCP, 2005) and for a single shower
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rnow).
CC BY-NC-ND license. Based on an average use of 20 g of soap per shower TCC can there-
fore be expected to reach concentrations of approximately 1 lM in
the blood stream. This was recently conﬁrmed in a study with hu-
man volunteers, where the use of TCC containing soap resulted in
half-maximal blood concentrations of up to 530 nM (Schebb et al.,
2012). Moreover, in the US its ubiquitous use has led to concentra-
tions as high as 6.8 lg/l in environmental water samples (Halden
and Paull, 2005). As a halogenated hydrocarbon TCC is hardly bio-
degradable (Aken et al., 2010; Furukawa and Fujihara, 2008;
Solyanikova and Golovleva, 2004) and subsequent levels in sewage
sludge easily exceed 50 mg/kg (Heidler et al., 2006). In combination
with the frequent use of sewage as fertiliser the poor biodegradabil-
ity thus further adds to human exposure (Wu et al., 2012).
The high levels of TCC in water and sewage have raised concerns
because TCC has been shown to amplify estrogenic and androgenic
responses in cell-based reporter assays (Ahn et al., 2008). Andro-
genic effects were also observed in vivo. In castrated rats the co-
administration of TCC and testosterone resulted in higher weights
of sex accessory organs (Chen et al., 2008). Respective hyperplasias
were also found in juvenile animals after they had been treated
with TCC (Duleba et al., 2011). Meanwhile the estrogenic effects
of TCC in vivo are less well investigated. In zebraﬁsh coexposure
to 17b-estradiol (E2) and TCC enhanced the transcriptional
Fig. 1. Chemical structures of the antimicrobials triclocarban (TCC), triclosan (TCS) and hexachlorophene (HCP).
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the xenoestrogen bisphenol A (BPA) led to reduced expression of
aroB (Chung et al., 2011).
Estrogens exert their effects mainly via two nuclear receptors,
that is estrogen receptor alpha (ERa) and beta (ERb). Following
cognate ligand binding these transcription factors dimerise and
bind to speciﬁc estrogen response elements (EREs) at the DNA,
where subsequent recruitment of co-activators induces target gene
expression (Heldring et al., 2007). Alternatively ERs can interact
with transcription factors already bound to the DNA, such as
AP-1 and Sp1. A third mechanism is the activation of non-genomic
pathways, where hormone binding leads to the rapid activation of
signalling cascades (Heldring et al., 2007).
Most estrogenic reporter gene assays use ERE-containing pro-
moters in combination with endogenous or transgenic ERa. Never-
theless, several estrogen responsive genes do not contain classical
EREs. Instead these promotors contain ERE half-sites, AP-1- and
Sp1-sites or combinations thereof (O’Lone et al., 2004). This sug-
gests the regulation of endogenous genes to be more complex
and questions the suitability of assays with readouts that are solely
based on ERE-driven gene expression. Therefore this study aimed
to compare the results of commonly used reporter gene assays
with the effects of TCC on endogenous gene expression in human
mammary carcinoma cells. The examined transcripts include
androgenic and estrogenic target genes as well as genes of the
AhR regulon. Androgenic gene expression was examined in an
ER background (i.e. MDA-MD-453), while MCF-7 cells were used
to test the inﬂuence of TCC in combination with E2 and a choice
of xenoestrogens typically found in consumer products, cosmetics
and foods (Evans et al., 2012).2. Materials and methods
2.1. Chemicals
Cell culture media were purchased from PAN Biotech (Aiden-
bach, Germany), charcoal treated FCS was obtained from PAA
(Cölbe, Germany) and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)
was a gift from the German dioxin reference lab (BfR, Berlin, Ger-
many). Substrates for the luciferase assays (D-Luciferin, ATP) and
reducing agent DTT were obtained from PJK (Kleinblittersdorf, Ger-
many). All other chemicals were purchased from Sigma Aldrich
(Munich, Germany). Substances were routinely dissolved in etha-
nol, with the exception of TCDD and TCC for which dimethylsulfox-
ide (DMSO) was used.
2.2. Androgen reporter assay
Cell line MDA-kb2 was obtained from the ATCC (ATCC-No. CRL-
2713). The MDA-kb2 cell line is a derivative of MDA-MD-453
breast cancer cells. The latter provide a well characterised molecu-
lar background for androgenic testing, as they express the andro-
gen receptor (AR) but are negative for ER. Transfection of this cell
line with a stable MMTV.luciferase.neo reporter gene constructyielded the MDA-kb2 reporter cell line which is responsive to stim-
ulation of the AR and the glucocorticoid receptor (GR) (Wilson
et al., 2002). Upon arrival in the lab cellular transcription of the
AR was conﬁrmed by quantitative RT-PCR, as was the absence of
transcripts for ER (Fig. S1). Reporter assays were performed as de-
scribed by Ermler et al. (2010). Brieﬂy, MDA-kb2 cells were main-
tained in Leibowitz’ L-15 medium supplemented with FCS (10% v/
v) and grown at 37 C without the provision of additional CO2. A
week before usage the cells were switched to phenol red free
L-15 medium with charcoal treated FCS (5% v/v). Subsequent seed-
ing into 96-well plates was done one day prior to exposure, using a
concentration of 104 cells per 100 ll and well. Substance exposure
was started after 24 h by adding 50 ll of concentrated substance
stocks. Dose response curves were measured in triplicate, and con-
trols (1 nM dihydrotestosterone (DHT) and 0.1% ethanol, respec-
tively) were repeated 6-fold.
Measurement of luciferase activity was performed in cellular
crude extracts using a Synergy HT plate reader from BioTek
(Bad Friedrichshall, Germany). Cells were lysed in situ using
50 ll of lysis buffer (0.1 M tris–acetate, 2 mM EDTA, and 1% tri-
ton-x, pH 7.8), shaking the plate moderately for 20 min at room
temperature. Following cellular lysis 150 ll of luciferase buffer
(25 mM glycylglycine, 15 mMMgCl2 and 4 mM EGTA, 1 mM
DTT, 1 mM ATP, pH 7.8) and 50 ll of luciferin solution (25 mM
glycylglycine, 15 mM MgCl2 and 4 mM EGTA, 0.2 mM luciferin,
pH 7.8) were added automatically to each well in order to mea-
sure luminescence. All values were corrected for the mean of
the negative control and then related to the positive control
which was set to 100%.2.3. Estrogen reporter gene assay
Cell line HeLa9903 was obtained from the JCRB (JCRB-No. 1318).
These cells contain stable expression constructs for human ERa
and ﬁreﬂy luciferase, respectively. The latter is under transcrip-
tional control of ﬁve ERE promoter elements from the vitellogenin
gene. The transcription of ERa was conﬁrmed by RT-PCR, as was
the absence of AR-transcripts (Fig. S1). The assay was performed
according to the OECD test guideline TG455 (OECD, 2009) as fol-
lows. Cells were cultivated in phenol red free MEM containing
10% (v/v) of charcoal stripped FCS at 37 C in an atmosphere with
5% CO2. For the actual assay cells were seeded into white 96-well
polystyrene plates at a concentration of 104 cells per 100 ll and
well (Costar/Corning, Amsterdam, Netherlands). Test substances
were added 3 h after seeding by adding 50 ll of triple concentrated
substance stocks to each well. As before dose response curves for
treated samples were measured in triplicate, while controls
(1 nM E2 or 0.1% ethanol, respectively) were repeated 6-fold. After
24 h of stimulation, cells were washed with PBS and then lysed
using 50 ll of lysis buffer and moderate shaking for 20 min at room
temperature. Subsequent measurement of luciferase activity was
performed analogous to the aforedescribed androgen reporter gene
assay. All values were corrected for the mean of the negative con-
trols and then related to the positive controls set as 100%.
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Cell line MCF-7 was obtained from the ATCC (ATCC-No. HTB-22)
and checked with RT-PCR for transcription of ER, AR, GPR30 and
AhR (Fig. S1). Cells were routinely passaged in RPMI 1640 medium
containing 10% FCS (v/v), 100 U/ml Penicillin and 100 lg/ml strep-
tomycin and grown at 37 C in an atmosphere with 5% CO2. Prior to
the actual assays the cells were transferred into hormone-free
medium (phenol red free RPMI 1640 with 5% of charcoal stripped
FCS). Cells were seeded into 96-well polystyrene plates at a density
of 1000 cells per 100 ll and well and were left to settle for 72 h be-
fore ﬁnally being exposed to the test substance for another 5 days.
Dose response curves were measured in triplicate, while controls
(1 nM E2 or 0.1% ethanol, respectively) were repeated 6-fold. Fol-
lowing substance exposure the cells were washed twice with PBS
before determining cellular protein using bicinchoninic acid (Ther-
mo Scientiﬁc, Waltham, MA, USA). After the addition of 25 ll H2O
and bicinchoninic acid solution the reaction was left to proceed for
another 30 min at 37 C before photometrically quantifying pep-
tide triggered Cu-complex formation in a Synergy HT plate reader
(kAbs = 562 nm).2.5. Determination of gene expression
Cell lines MCF-7 or MDA-kb2 were seeded into 12-well plates
with hormone-free medium at a concentration of 2  105 cells per
ml andwell. After 48 h of initial incubation the cells were stimulated
with test substances for 6 or 24 h, respectively. Following substance
treatment cells were washed in PBS and the total RNAwas extracted
using Trizol (Invitrogen, Carlsbad, CA, USA). The extracted RNA (1 lg)
was reversely transcribed into cDNA, using a cDNA synthesis kit (Ap-
plied Biosystems, Foster City, CA,USA). Relative transcript levelswere
determined in triplicate by quantitative RT-PCR, using presynthes-
ised Taqman probes or speciﬁc primers for a SYBR green master
mix (Applied Biosystems, Foster City, CA, USA). Taqman probes and
primer sets used were GAPDH (Hs02758991_g1), RPLP0 (Hs999
99902_m1), CYP1A1 (Hs0015 3120_m1), CYP1B1
(Hs00164383_m1), PGR (Hs0155 6707_m1), TFF1 (Hs001
70216_m1), CCND1 (Hs00277039_m1), HSPB8 (Hs00 205056_m1),
UGT2B15 (Hs030 08769_g1), ESR1 (Hs01 046812_m1), ESR2
(Hs01100356_m1), AR (Hs00907244_m1) and GPR30
(Hs01922715_s1). The following primers were used in conjunction
with SYBR green: SARG-forward (50-CAG CTA CGA CTT CCT GTC
CAC-3)0, SARG-reverse (50-TGC TGA GTG ATG GTC TCC TCT-3)0,
NDRG1-forward (50-AAC CTG CAC CTG TTC ATC AAT-30), NDRG1-
reverse (50-GGT CTT TGT TGG GTC CAA TTT-30), FASN-forward (50-
AAT GTC AAC AAC CTG GTG AG-30), FASN-reverse (50-CCC TGT GAT
CCT TCT TCA TCA-30), GAPDH-forward (50-CTC TGC TCC TCC TGT
TCG AC-30) and GAPDH-reverse (50-ACG ACC AAA TCC GTT GAC TC-
30). Relative gene expression was calculated using the DDCt method
and normalised to expression levels of GAPDH or RPLP0.2.6. siRNA mediated gene knockdown
Gene transcription of target genes was knocked down using a
commercial siRNA transfection kit (‘HiPerFect’, Qiagen, Hilden,
Germany). Brieﬂy, MCF-7 cells were seeded into 12-well plates into
hormone-free medium at a density of 1.2  105 cells per well. Fol-
lowing a 24 h pre-incubation the transfection was commenced
according to the manufacturer’s instructions, using 2 nM of
gene-speciﬁc or control siRNA, respectively. After 48 h of cellular
recovery the efﬁciency of knockdowns was checked by quantita-
tive RT-PCR.2.7. Ethoxyresoruﬁn-O-deethylase (EROD) assay
Cytochrome P450 (CYP)-catalysed turnover of 7-ethoxyresoru-
ﬁn by MCF-7 cells was measured in 96-well plates. The cells were
seeded into phenol red free RPMI charcoal stripped FCS (5% v/v) at
a density of 104 cells per well and allowed to rest for 48 h before
being subjected to a 24 h test substance exposure. Cells were then
washed twice with serum and phenol red free RPMI before 5 lM
7-ethoxyresoruﬁn and 20 lM dicumarol were added to the wells.
Subsequent ﬂuorescence readouts were recorded continuously at
37 C in a Synergy HT microplate reader (kex = 530 nm, kem = 585
nm) and the respetive activity of CYP1 enyzmes was calculated
based on a calibration curve with resoruﬁn. Protein concentrations
were measured using a BCA protein kit (Thermo Scientiﬁc, Wal-
tham, MA, USA). All measurements were performed as 6-fold
replicates.
2.8. Thermal shift assay
Protein stability of ﬁreﬂy luciferase (Promega, Madison, WI,
USA) was assayed by ﬂuorescent thermal shift (Niesen et al.,
2007; Vedadi et al., 2006). Assays were performed in 96-well PCR
plates using 3.6 lM of protein, 2 mM ATP and SYPRO orange in
50 mM tris–acetate, pH 7.6. Ligands, such as TCC, were added as
indicated. Subsequent thermal shifts ranged from 25 C to 99 C
at an increment of 1 C/min and were recorded using the ROX ﬁlter
set of a HT7500 PCR cycler (Applied Biosystems, Foster City, CA,
USA). Data were analysed and the temperature of half-maximal
denaturation (Tm) was calculated using the MS Excel spreadsheets
as provided by (available at ftp:// ftp.sgc.ox.ac.uk /pub /biophysics)
(Niesen et al., 2007; Vedadi et al., 2006).
2.9. Statistical analysis
All experiments were done in triplicate at least. Plotted error
bars refer to the standard error of the mean (SEM) and a two-tailed
Student’s t-test was used to assess signiﬁcance. Respective
p-values of p < 0.05 are indicated by an asterisk as appropriate.3. Results
Concerns about an androgenic potential of TCC are mainly
fuelled by results obtained from luciferase-based reporter screens
(Ahn et al., 2008; Christen et al., 2010). However, the suitability
of such systems as sole indicators for potential endocrine activity
is disputed (Diel et al., 1999; Baker, 2001; Thorne et al., 2010).
To investigate the androgenic potential of TCC this study therefore
supplemented a commonly used AR-sensitive cellular luciferase
assay with quantitative RT-PCR. The concentration of TCC used in
the assays was 1 lM as this corresponds to the maximal levels
realistically expected in human blood (SCCP, 2005; Schebb et al.,
2012).
3.1. Effects on androgen regulated endogenous target genes of TCC in
combination with dihydrotestosterone in MDA-kb2 cells
Initially the reported androgen mediated ampliﬁcation of lucif-
erase-activity by TCC was reproduced using a MDA-kb2 reporter
cell line (Fig. 2). In contrast to the T47D-ARE cell line used previ-
ously (Ahn et al., 2008) this cell line originates from human
MDA-MB-453 breast cancer cells which were transfected with a
MMTV.luciferase.neo reporter construct. The respective reporter
is negative for ER but maintains endogenous expression of the
AR (Christen et al., 2010). The molecular background thus allows
the monitoring of AR-responsive genes, while the luciferase
Fig. 2. Exposure to TCC ampliﬁes DHT-triggered luminescence in MDA-kb2 reporter cells (A) but does not inﬂuence transcript levels of AR target genes (B–D). Cells were
seeded in hormone-free medium for 24 (A) or 48 h (B–D) before being exposed to DHT ±1 lM TCC as indicated. Substance exposure was maintained for 24 h. Reporter gene
activity was recorded as substance triggered change in ﬂuorescence and is plotted relative to the activity of the positive control (1 nM DHT) (A). In a parallel experiment
transcript levels of SARG, NDRG1 and SORDwere followed using RT-PCR and SYBR-green. Gene expression levels shown are normalised to endogenous transcription of GAPDH
(B–D). All data shown represent the mean of three independent experiments (±SEM).
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GR. Quantitative RT-PCR conﬁrmed expression of the AR, GPR30
and AHR as well as the absence of transcripts for ERa or ERb
(Fig. S1). As anticipated co-exposure to 1 lM TCC and varying con-
centrations of DHT ampliﬁed the luciferase reporter activity by
40% (Fig. 2A). Meanwhile the corresponding EC50 values re-
mained unchanged at 8.0  1011 M and 8.2  1011 M for control
and TCC treated cells, respectively. Nevertheless, the suggestedFig. 3. Effect of TCC in a luciferase dependent estrogen receptor transactivation
assay (HeLa9903). Cells containing an ER sensitive ﬁreﬂy luciferase construct were
stimulated with increasing concentrations of E2 ±1 lM TCC for 24 h. Any substance
triggered changes in luminescence were subsequently recorded using a plate
luminometer. All values were corrected for background luminescence and are
plotted as percent luminescence of the positive control (1 nM E2). The data shown
represent the mean (±SEM) of three independent experiments, each performed in
triplicate.stimulation of the AR is in line with earlier studies, which conﬁrms
the functionality of the reporter construct (Christen et al., 2010).
The next aim was to validate the AR-antagonistic function of
TCC on a transcriptional level. This was done by RT-PCR, targeting
several transcripts known to be regulated by the AR (i.e. SARG,
NDRG1 and SORD) (Doane et al., 2006). Prior to RNA-extraction
the cells were treated for 24 h with 1 or 10 nM DHT ± 1 lM TCC,
respectively. Exposure to DHT led to an increased expression of
all three transcripts. Yet, in the presence of TCC only SORD showed
a slight but statistically signiﬁcant decrease in gene expression
(p = 0.02) (Fig. 2D). It was thus not possible to conﬁrm the initially
observed androgenic effect of TCC on the level of the AR regulon.
An unspeciﬁc off-target effect of TCC on luciferase should, how-
ever, be apparent independent of the receptor investigated. Hence
an estrogenic luciferase reporter was used to investigate the effects
of TCC in presence of estrogen (E2). The corresponding results were
then compared with those of a commonly used proliferation assay,
namely the E-screen.
3.2. TCC ampliﬁes the estrogen response in an estrogen dependent
reporter gene assay but not in a mitogenic estrogen assay
The effect of TCC on an estrogenic luciferase reporter was stud-
ied using HeLa9903 cells, a cell line previously suggested for the
detection of xenoestrogens by the OECD and EPA (OECD, 2009).
These cells are stably transfected with human ERa and an ERE-
driven luciferase reporter gene. The molecular phenotype was ver-
iﬁed by quantitative RT-PCR, detecting transcripts of ESR1, GPR30
and AHR but not AR or ESR2 (Fig. S1). As described previously
(Ahn et al., 2008) cellular co-exposure to E2 and 1 lM TCC resulted
in a 50% increase of luciferase signal intensity (Fig. 3). Although
Fig. 4. Effect of TCC on estrogen dependent cell proliferation (E-screen). Following
their synchronisation in hormone-free medium MCF-7 breast cancer cells were
exposed to different concentrations of E2 ±1 lM TCC. Cell proliferation was
quantiﬁed as relative protein content per well. The data shown represent the mean
(±SEM) of three independent experiments, each performed in triplicate and
corrected for the background measured in the negative control.
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(1011 to 108 M), the maximal effect was seen at 1 nM E2 and
1 lM TCC (Fig. 3). Higher concentrations of TCC quickly became
cytotoxic (Fig. S2).
The suggested xenoestrogenic potential of TCC was further
examined using the E-screen (Fig. 4). This assay uses the estrogen
dependent proliferation of human mammary carcinoma MCF-7
cells as readout. Cellular exposure to E2 triggered a dose depen-
dent increase of MCF-7 cell numbers. Addition of 1 lM TCC, how-
ever, failed to have any further proliferative effect. The E2
concentrations producing 50% of the maximal effect (EC50) were
comparable between the two assays, ranging from 2.9  1011 M
for the luciferase assay to 3.0  1011 M for the E-screen. Never-
theless, while co-stimulation with TCC and E2 resulted in an in-
crease of luciferase triggered luminescence, it failed to have any
major effect on E2 dependent cell proliferation or the EC50
(2.1  1011 M and 1.6  1011 M).3.3. Effects of TCC on estrogen regulated endogenous target genes in
MCF-7 cells
With hindsight to the previous reports of TCC acting as a xeno-
estrogen in vivo (Chung et al., 2011) potential effects of TCC on the
cellular estrogen response were further investigated on a molecu-
lar level. This was done using MCF-7 cells. As an established estro-
gen responsive cell line these cells endogenously express ERa as
well as the estradiol-sensitive GPR30 (Fig. S1). In absence of any
other reporter constructs they therefore allow a reliable detection
of potential transcriptional changes caused by xenoestrogens.
Quantitative RT-PCR was therefore used to follow the transcrip-
tional pattern of several estrogen regulated genes in response to
co-stimulation with TCC and E2 (10 nM) or various xeno- and phy-
toestrogens. Bisphenol A (BPA, 10 lM) and butylparaben (10 lM)
were chosen as well-characterised xenoestrogens while genistein
(10 lM) was used as a phytoestrogen. Analogous to the cellular as-
says test substance stimulation was maintained for 24 h in pres-
ence or absence of 1 lM TCC. In addition cells were also
subjected to a 6 h treatment in order to detect any potential short
term effects (e.g. as consequence of a short-term exposure, such as
a shower with TCC-containing soap). The four transcripts used as
molecular readouts for the 6 h treatment (Table 1) were chosen
to reﬂect the various promoter structures of estradiol regulated
genes. The promoters of the progesterone receptor (PGR) and the
trefoil factor 1 (TFF1 or pS2) contain an AP-1 site and an EREhalf-site or a combination of several EREs and AP-1 binding sites,
respectively (O’Lone et al., 2004; Cavailles et al., 1989). In contrast
expression of cyclin D1 (CCND1) is regulated by tethered estrogen
receptor signalling using Sp1 and AP-1 sites (Liu et al., 2002),
whereas the 22 kDa heat shock protein 8 (HSPB8) is reported to
be partially regulated by non-genomic estrogen signalling (Sun
et al., 2007; Madak-Erdogan et al., 2008). Cellular exposure to
any of the estrogens resulted in elevated transcript levels for all
four genes. Meanwhile treatment with TTC did not have any effect.
Neither did exposure to TCC alone alter the transcript levels of any
of the ER regulated genes, nor did co-exposure to estrogens and
TCC change estrogen-induced levels of gene expression.
The experiment was repeated with a prolonged substance expo-
sure of 24 h (Table 1). Under these conditions expression levels of
CCND1 and HSPB8 are known to decrease though (data not shown)
(Silva et al., 2010). Therefore two other transcripts were chosen as
molecular readouts instead, that is the genes for ERa (ESR1) and
glucuronosyltransferase 2B15 (UGT2B15) (Hu and Mackenzie,
2009). The latter also has a prominent role during detoxiﬁcation
of BPA (Völkel et al., 2002; Hanioka et al., 2008). Expression of
ESR1 is reported to be regulated via an ERE half-site, while the tran-
scription of UGT2B15 is coordinately regulated by E2 via AP-1 sites,
imperfect EREs and ERE half-sites (O’Lone et al., 2004; Hu and
Mackenzie, 2009; Harrington et al., 2006). As before all transcripts
were altered following estrogenic treatment. For PGR and ESR1
treatment with BPA, butylparaben and genistein had an effect sim-
ilar to E2, unlike UGT2B15 where the two xenoestrogens had a less
pronounced effect. With regard to trefoil factor 1 the prolonged
exposure with genistein led to a 10-fold upregulation, a level twice
as high as with E2. Again, none of the tested transcripts was inﬂu-
enced either by TCC alone or by co-stimulation with TCC and estro-
gens. Altogether the experiments therefore did not conﬁrm a
potential xenoestrogenic effect of TCC, neither on the molecular le-
vel, nor in whole cells (E-screen).
3.4. TCC stabilises ﬁreﬂy luciferase in vitro
Meanwhile the conﬂicting results for TCC in the various test
systems point to an unspeciﬁc effect on luciferase. Ligand triggered
stabilisation of luciferase has previously been reported to cause
false positive readouts (Thorne et al., 2012). We therefore used
thermal shift to assay the effects of TCC and ATP on the enzymes
heat stability (Fig. 5A). The results showed that TCC indeed directly
interacts with ﬁreﬂy luciferase, stabilising the enzyme. The effect is
particularly pronounced in the presence of ATP as enzymatic cofac-
tor. Addition of the latter shifted the Tm of luciferase by 3.3 C.
However, with increasing concentrations of TCC this shift in-
creased further to up to 7 C at 10 lM TCC. No such strong interac-
tion could be seen with structural similar antimicrobials such as
TCS and HCP (Fig. 5B). The ﬁrst did not to stabilise luciferase at
all, while the latter only interacted weakly (DT5 lM HCPm = 2 C).
Tested in the HeLa9903 estrogen reporter assay both substances
were negative (Fig. S2).
3.5. Effects of TCC on target genes of the AhR
Altogether the data indicate that the previously reported effects
of TCC as a xenohormone in vivo are not related to a direct interac-
tion with the AR or ER. It is well established though that AhR and
ERa are connected via a complex regulatory crosstalk mediated by
several mechanisms and that interference with this crosstalk can
lead to adverse phenotypes (Rataj et al., 2012). On molecular level
interactions comprise competition for co-activators as well as AhR
mediated protein degradation of ERa by ubiquitinylation (Ohtake
et al., 2011). Further on some AhR regulated genes such as CYP1B1
are also known to be ERE regulated (Tsuchiya et al., 2004).
Table 1
Effect of TCC on target genes of the ER in MCF-7 cells following 6 h or 24 h of co-stimulation with estrogens. Cells were pre-incubated in hormone-free medium for 48 h before
being exposed to E2 (10 nM), BPA (10 lM), butylparaben (BuPa, 10 lM) or genistein (Gen, 10 lM) in the presence of ±1 lM TCC, respectively. Relative gene expression of selected
ER regulated genes was subsequently quantiﬁed with Taqman probes using real-time PCR. Target gene expression was normalised to the transcription level of endogenous GAPDH
and is reported as fold change compared to the untreated control (mean ± SEM). None of transcriptional differences between DMSO- and TCC-treated samples was found to be
statistically signiﬁcant (p > 0.05).
Gene symbol Ctrl E2 BPA BuPa Gen
DMSO TCC DMSO TCC DMSO TCC DMSO TCC DMSO TCC
6 h
PGR 1.00 ± 0.01 0.97 ± 0.03 24.16 ± 2.33 24.48 ± 2.7 24.11 ± 2.93 28.01 ± 2.87 24.81 ± 1.18 25.97 ± 2.06 29.79 ± 1.92 30.57 ± 3.03
TFF1 1.01 ± 0.05 1.06 ± 0.04 3.41 ± 0.43 3.65 ± 0.35 3.64 ± 0.13 4.13 ± 0.45 3.237 ± 0.30 3.90 ± 0.51 4.96 ± 1.02 5.25 ± 0.58
HSPB8 1.00 ± 0.02 1.00 ± 0.05 10.25 ± 0.67 10.73 ± 1.10 9.43 ± 1.28 10.2 ± 0.51 9.44 ± 0.62 9.69 ± 1.02 12.12 ± 0.52 12.57 ± 0.75
CCND1 1.00 ± 0.01 1.00 ± 0.08 2.41 ± 0.04 2.63 ± 0.09 2.34 ± 0.17 2.46 ± 0.16 2.41 ± 0.03 2.43 ± 0.20 2.59 ± 0.21 2.98 ± 0.22
24 h
PGR 1.00 ± 0.02 0.89 ± 0.14 23.52 ± 0.77 22.32 ± 0.94 25.31 ± 1.25 24.69 ± 1.86 29.65 ± 2.74 23.10 ± 1.55 29.12 ± 3.47 29.74 ± 4.75
TFF1 1.00 ± 0.02 0.96 ± 0.06 5.51 ± 0.63 5.51 ± 0.40 4.77 ± 0.58 5.01 ± 0.30 4.95 ± 0.41 4.45 ± 0.21 10.83 ± 0.79 9.01 ± 0.78
ESR1 1.00 ± 0.02 1.01 ± 0.03 0.35 ± 0.01 0.35 ± 0.03 0.44 ± 0.04 0.45 ± 0.05 0.48 ± 0.07 0.43 ± 0.07 0.53 ± 0.10 0.52 ± 0.11
UGT2B15 1.00 ± 0.02 1.02 ± 0.08 11.62 ± 0.25 10.72 ± 0.96 5.42 ± 0.61 5.07 ± 0.52 4.61 ± 0.73 3.99 ± 0.50 9.12 ± 2.42 9.08 ± 1.37
Fig. 5. TCC inﬂuences thermal stability of puriﬁed luciferase. Thermal enzyme stability (1 C/min) was assayed using 3.6 lMﬁreﬂy-luciferase in presence of TCC ± ATP (A) and
TCS or HCP with ATP (B) as indicated. Fluorescence of SYPRO-orange was recorded continuously in a thermocycler, covering a temperature interval of 25–99 C. Different
melting curves are plotted as relative changes in Tm and refer to luciferase in presence of 2 mM ATP as stabilising cofactor. The data plotted represent the mean of three
independent experiments, each performed in triplicate (±SEM).
Fig. 6. Effect of TCC on the AhR target genes CYP1A1 and CYP1B1 in MCF-7 cells following 24 h of co-stimulation with estrogens. Cells were pre-incubated in hormone-free
medium for 48 h before being exposed for another 24 h to E2 (10 nM), BPA (10 lM), BuPa (10 lM) or Gen (10 lM) in the presence of ±1 lM TCC, respectively. Relative gene
expression of selected genes was subsequently quantiﬁed with Taqman probes using real-time PCR. Target gene expression was normalised to the transcription level of
endogenous GAPDH. Panels show the results for CYP1A1 and CYP1B1. The data represent the mean of three independent experiments (±SEM).
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measured the expression of two classical target genes of the AhR,
CYP1A1 and CYP1B1 (Fig. 6). Used as single substance TCC induced
a slight increase in CYP1A1 expression which was comparable to
the treatment with genistein. None of the other estrogens had a
comparable effect when used alone. However, in combination with
TCC they acted as strong inducers, increasing transcription of
CYP1A1 by up to 20-fold. Moreover, while all estrogens acted asinducers for CYP1B1, co-exposure to TCC stimulated transcription
even further. On the other hand treatment with TCC alone only
had a marginal effect on CYP1B1 gene expression. The results indi-
cate TCC to be a co-stimulator of the AhR. This is further supported
by the fact that siRNA mediated reduction of AHR transcript levels
to 25% strongly reduced the co-stimulatory effects of TCC and E2
on CYP induction (Fig. 7A). Meanwhile knockdown of ESR1
produced a similar result. The reduction of ERa by 85% basically
Fig. 7. Effect of AhR and ERa knockdown on transcript levels of CYP1A1 and 1B1 in MCF-7 cells. Following transfection with gene-speciﬁc siRNA the successful knockdown of
AHR (A) or ESR1 (B) was conﬁrmed using RT-PCR and by Western Blot (ERa only, inset). Cells were stimulated with 10 nM E2 ±1 lM TCC for 24 h. Transcript levels of CYP1A1
or CYP1B1were quantiﬁed using Taqman probes and real-time PCR. Gene expression levels were normalised to the transcription of endogenous RPLP0. The data represent the
mean of three independent experiments (±SEM).
Fig. 8. Antagonistic effect of TCC on TCDD-induced gene expression (A) and enzymatic activity (B) of CYP1A1 in MCF-7 cells. Cells were pre-incubated in hormone-free
medium for 48 h before being exposed for another 24 h to various concentrations of TCDD ±1 lM TCC, respectively. Transcript levels of CYP1A1were quantiﬁed using Taqman
probes and real-time PCR. Gene expression levels were normalised to the transcription of endogenous GAPDH (A). Enzymatic activity was followed in a parallel experiment,
quantifying CYP1A1-catalysed resoruﬁn-formation ﬂuorometrically (B). Data plotted represent the mean of three independent experiments (±SEM).
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transcription (Fig. 7B). It therefore appears that AhR as well as
ERa are essential for the co-stimulatory effect of TCC on CYP1
expression. A direct interference of TCC with the AhR has also been
suggested by Ahn et al. who identiﬁed TCC to be a weak AhR antag-
onist in cells treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD) (Ahn et al., 2008). Treatment of TCDD-exposed MCF-7 cells
with 1 lM TCC indeed inhibits endogenous expression of CYP1A1
(Fig. 8A). The inhibitory effect is maintained throughout a concen-
tration range of 10–100 pM TCDD, above which TCC seems to be
outcompeted. An EROD assay further conﬁrmed these results,
showing that TCC also inhibited CYP1A1mediated resoruﬁn forma-
tion (Fig. 8B). This inhibition of a classical AhR cascade is incontrast to the co-stimulation of estrogenic CYP-induction seen be-
fore and demonstrates a differentiated effect of TCC on the AhR sig-
nalling cascade.4. Discussion
This study investigated the endocrine effects of TCC using dif-
ferent in vitro assays. Despite its widespread use and its disputed
role as an endocrine disruptor there are only few studies that
looked into the molecular effects of TCC exposure. Most of the pub-
lished data about the estrogenic or androgenic effects of TCC come
from studies that used luciferase-based reporter assays. These
1474 P. Tarnow et al. / Toxicology in Vitro 27 (2013) 1467–1475cellular assays are ideal for high-throughput screening due to their
ease of handling and their automated readout. Hence they have be-
come a tool of choice for the screening and investigation of poten-
tial endocrine disruptors and environmental pollutants. An
androgenic action of TCC has been suggested repeatedly based on
various androgenic transactivation assays (i.e. T47D-ARE cells,
MDA-kb2 cells, or transiently transfected LnCaP or C4-2B cells)
(Duleba et al., 2011; Chen et al., 2008; Blake et al., 2010; Ahn
et al., 2008; Christen et al., 2010). The MDA-kb2 luciferase assay
used in this study indeed conﬁrmed TCC to enhance the DHT med-
iated luciferase signal. Yet, TCC failed to increase transcription of
several androgen responsive genes when tested in the same molec-
ular background. This suggests an interaction of TCC with lucifer-
ase instead. The latter is conﬁrmed further by the results of the
estrogenic reporter assays.
The estrogenic effect of TCC was previously shown in BG1-ERE
cells (Ahn et al., 2008). Derived from ovarian cancer cells, this cell
line has been stably transfected with an ERE-driven ﬁreﬂy lucifer-
ase reporter construct. Receptor ERa is expressed endogenously in
these cells. In contrast the HeLa9903-reporter recommended by
the OECD and EPA (OECD, 2009) supplies the ERE-driven luciferase
construct as well as the ERa transgenetically. Nonetheless, the pre-
viously reported estrogen amplifying effect of TCC was also seen
with the HeLa9903 cells. In addition, the exposure triggered in-
crease of luminescence and the dose response curves for TCC were
comparable to those published by Ahn et al. (2008). However, TCC
did not show any further xenoestrogenic activity in a subsequent
proliferation assay (Soto et al., 1995). Moreover, the expression
of known estrogen responsive genes remained unaffected as well.
The only notable exception was CYP1B1, a known target gene of
the ER as well as the AhR (Tsuchiya et al., 2004; Shen et al., 1994).
Altogether the results suggest that the effects seen with TCC in
luciferase-based transactivation assays are due to interference
with ﬁreﬂy luciferase, rather than being triggered by ERa or the
AR. Similar false positives have been reported in previous high-
throughput screens (Thorne et al., 2010). A recent screen of the
NIH Molecular Libraries Small Molecule Repository identiﬁed 12%
of the 360,864 molecules to be inhibitors of ﬁreﬂy luciferase
(Thorne et al., 2012). In some cases inhibition paradoxically re-
sulted in an increase of the luminescence signal, probably because
of enzyme stabilisation (Sotoca et al., 2010). Such a mode of action
is also supported by the PubChem Bioassay Database (http://pub-
chem.ncbi.nlm.nih.gov) which quotes a preliminary EC50 of
8.9 lM TCC for the inhibition of luciferase. Thermal shift assays in-
deed conﬁrmed a strong stabilising interaction of TCC with lucifer-
ase at ligand concentrations above 5 lM. The effective
concentration for TCC is likely to be even lower in cellular assays
as these have more physiological buffer conditions.
In absence of a direct receptor interaction the androgenic and
estrogenic effects seen with TCC in vivo are thus likely to be the re-
sult of a mechanism different from classical AR- or ER-signalling
(Chen et al., 2008; Duleba et al., 2011; Chung et al., 2011). A prime
target for endocrine crosstalk is the AhR, which is known to inﬂu-
ence the cell’s response to estrogens as well as androgens (Morrow
et al., 2004; Wormke et al., 2003; Ohtake et al., 2007). Our results
indeed show an interference of TCC with the AhR regulon. In pres-
ence of the model substrate TCDD it acts as an antagonist for the
AhR, effectively inhibiting TCDD-triggered induction of CYP1A1.
In addition, exposure to TCC was sufﬁcient to increase transcrip-
tion of CYP1A1, while co-exposure together with estrogens led to
strong induction of CYP1A1 and CYP1B1. As classical phase I en-
zymes CYP1B1 and CYP1A1 are regulated by AhR, the latter exclu-
sively so (Nebert et al., 2004). Monooxygenase CYP1B1 on the
other hand is known to be also co-regulated by estrogens (Tsuchiya
et al., 2004). However, the fact that TCC failed to show estrogenic
effects but clearly acted co-stimulatory on CYP1B1 expressionpoints to an AhR-mediated response. The observation of TCC as a
moderate agonist of the AhR is further supported by Yueh et al.
who report induction of CYP1B1 at near cytotoxic concentrations
(5–25 lM TCC) (Yueh et al., 2012; Ahn et al., 2008). At these high
concentrations CYP1B1 gene induction did not require co-stimula-
tion with estrogens. The effect depended nevertheless on the pres-
ence of functional ERa, which is consistent with the results of the
ERa knockdown in this study. It thus seems, that while the induc-
tion of the respective luciferase reporter is an unspeciﬁc false posi-
tive effect caused by luciferase stabilisation, TCC has the potential
to interfere with the regulatory crosstalk of the estrogen receptor
and the AhR regulon.
Reporter gene assays are a simple and fast tool to screen for hor-
monal activity. However, they should be used with their limita-
tions in mind and results should be veriﬁed with independent
assays in order to reduce false positives and false negatives alike
(Bovee and Pikkemaat, 2009). For substances that can directly
interact with luciferase, such as TCC, the respective reporter assays
are an unsuitable tool to investigate any potential endocrine prop-
erties. As shown in this study TCC has the potential to lower the
transcriptional threshold of classical AhR target genes such as
CYP1A1 and CYP1B1. Endocrine effects observed in vivo might thus
not be directly mediated by interaction with the AR or ER but result
from an interference with the AhR regulon. Hence future molecular
hazard assessments should focus on the possible co-exposure to
TCC and xenoestrogens.
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